XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current Assets:    
Cash and cash equivalents $ 226,748 $ 523,506
Marketable securities 685,475 669,116
Accounts receivable ($0.2 million and $0.3 million, respectively,from related party) 36,456 3,768
Prepaid expenses and other current assets 49,651 20,407
Total current assets 998,330 1,216,797
Marketable securities - noncurrent 99,864 69,338
Property and equipment, net 32,760 27,921
Operating lease right-of-use assets 115,375 133,076
Equity method investment 11,765 32,455
Investments and other assets 42,883 40,527
Total Assets 1,300,977 1,520,114
Current Liabilities:    
Accounts payable 7,452 5,154
Accrued expenses ($1.0 million and $1.6 million, respectively, from related party) 67,017 60,876
Current portion of operating lease liability 18,599 16,685
Current portion of deferred revenue ($0 and $19.9 million, respectively,from related party) 22,140 43,839
Total current liabilities 115,208 126,554
Deferred revenue, net of current portion 38,853 19,932
Long-term operating lease liability 96,747 114,018
Contingent consideration liability 0 24,026
Total liabilities 250,808 284,530
Commitments and contingencies (Note 8)
Stockholders’ Equity:    
Common stock, $0.0001 par value; 240,000,000 and 120,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively;92,997,158 and 87,103,007 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 9 9
Additional paid-in capital 2,710,797 2,420,223
Accumulated other comprehensive loss (2,258) (7,461)
Accumulated deficit (1,658,379) (1,177,187)
Total stockholders’ equity 1,050,169 1,235,584
Total Liabilities and Stockholders’ Equity $ 1,300,977 $ 1,520,114